Emerald Acquisition’s Sagent Pharmaceuticals SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-524,293
Closed -$7.85M – 3152
2016
Q2
$7.85M Buy
+524,293
New +$6.74M 0.01% 1058

Emerald Acquisition's SGNT Position: Q3 2016 in Review

Emerald Acquisition sold out of Sagent Pharmaceuticals (SGNT) in Q3 2016, closing a stake of 524,293 shares — an estimated $7.85M sold.

Emerald Acquisition first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $7.85M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Emerald Acquisition reported no remaining Sagent Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Emerald Acquisition sold 524,293 Sagent Pharmaceuticals shares in Q3 2016, an estimated $7.85M.
  • Emerald Acquisition first reported a position in Sagent Pharmaceuticals in Q2 2016 and held it in 1 quarter.
  • Emerald Acquisition's Sagent Pharmaceuticals position peaked at $7.85M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sagent Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.